Aplicación YC de Nomic Bio

Winter 2020Active

Nomic Bio pasó por Y Combinator en el batch Winter 2020 como una empresa de Healthcare. Abajo: qué hace la empresa, quién la fundó y su aplicación a YC, reconstruida pregunta por pregunta en el formulario real de YC.

Batch YC: Winter 2020
Industria: HealthcareDiagnostics
Tamaño del equipo: 24
Estado: Active
Lanzado: 2020

Fundadores

Milad DagherFounder
Jeff MunzarFounder

Lo que hace Nomic Bio

Nomic is doing for protein profiling, what Illumina did for DNA sequencing. Our core technology, the nELISA, is a next-gen immunoassay platform that transforms the ELISA into a high-throughput, high-content, and high-versatility tool. Today we developed the nELISA for high-throughput drug discovery scientists, enabling them profile 100s of proteins at 10x higher throughput and 10x lower cost compared to existing solutions. We're offering the nELISA through early access programs to HTS groups in top pharmas as well as pioneering biotechs in the space. Our goal is to create a ubiquitous technology that consolidates the broad range of legacy immunoassay toolkits that scientists use today with a single platform that can carry the science end-to-end, from discovery all the way to the clinic. We're a team of engineers, biologists, and highly-skilled lab operators that are looking to grow quickly to keep up with customer demand but also to continue developing our core technology, scale our multiplexing/throughput, and build our software stack. We're hiring on a number of positions including engineering, software, biology, and ops. Come talk to us!

Aplicación YC de Nomic Bio, reconstruida

Solicitud de Y Combinator

Nomic Bio, batch Winter 2020. Las preguntas reales del formulario, respondidas con datos públicos.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Nomic Bio

Describe what your company does in 50 characters or less.

Protein profiling like Illumina did for DNA

What is your company going to make? Please describe your product and what it does or will do.

We built the nELISA, a next-generation immunoassay platform that lets drug discovery scientists profile hundreds of proteins simultaneously with 10x higher throughput and 10x lower cost than current solutions. Unlike legacy ELISA kits, our platform scales high-content protein measurement for early discovery through to clinical use, consolidating multiple assay types into one versatile tool.

Where do you live now, and where would the company be based after YC?

We live in Montreal, QC, Canada, and plan to keep the company based here after YC.

Explain your decision regarding location.

Montreal has the local expertise in biochemistry, engineering, and nanotech that our platform requires. It also offers a strong, low-cost talent pool compared to typical US hubs and aligns with the founders' personal ties and initial lab setup.

21 respuestas más en la aplicación completa

están en la versión completa. Crea una cuenta gratuita para abrirla en YC Insights, junto a cada otro batch de YC.

Ver aplicación completa

Preguntas Frecuentes

¿Es esta la aplicación YC real de Nomic Bio?

No. Y Combinator mantiene privadas las aplicaciones enviadas. Esta es una reconstrucción: las preguntas reales del formulario de YC, respondidas a partir de los datos públicos de Nomic Bio (notas de lanzamiento, antecedentes de fundadores, descripción del producto). Muestra cómo una empresa como Nomic Bio se presentaría a YC, no el texto que enviaron.

¿En qué batch de YC estuvo Nomic Bio?

Nomic Bio formó parte del batch Winter 2020 de Y Combinator.

¿Quién fundó Nomic Bio?

Nomic Bio fue fundado por Milad Dagher, Jeff Munzar.

¿A qué se dedica Nomic Bio?

Nomic is doing for proteins what Illumina has done for DNA

¿Cómo leo la aplicación completa reconstruida?

Crea una cuenta gratuita de Round Funded. La versión completa de 26 respuestas de la aplicación de Nomic Bio, y de cada otro batch de YC, está en YC Insights.